TFA
AZN icon

Tobias Financial Advisors’s AstraZeneca AZN Stock Holding History

Tobias Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Hold
1,251
– – 0.03% 135
2026
Q1 		$247K Sell
1,251
-71
-5% -$13.7K 0.03% 128
2025
Q4 		$243K Buy
+1,322
New +$232K 0.03% 127

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tobias Financial Advisors's AZN Position: Q2 2026 in Review

Tobias Financial Advisors held its AstraZeneca (AZN) position steady in Q2 2026 at 1,251 shares worth $237K. The position accounts for 0.03% of the portfolio, ranked #135.

Tobias Financial Advisors first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $247K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Tobias Financial Advisors held 1,251 shares of AstraZeneca worth $237K as of Q2 2026.
  • Tobias Financial Advisors left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.03% of Tobias Financial Advisors's portfolio in Q2 2026, its #135 holding.
  • Tobias Financial Advisors first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Tobias Financial Advisors's AstraZeneca position peaked at $247K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tobias Financial Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.